Guangdong Transtek Medical Electronics Co., Ltd (SHE:300562)

SHE:300562 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	978.81	978.02	878.91	1,060	1,816	1,333
Other Revenue	5.96	5.96	5.35	4.97	4.82	3.89
Revenue	984.77	983.98	884.26	1,065	1,821	1,337
Revenue Growth (YoY)	-4.63%	11.28%	-16.98%	-41.51%	36.23%	51.27%
Cost of Revenue	651.46	645.88	606.35	844.21	1,486	1,001
Gross Profit	333.31	338.1	277.9	220.88	335.31	335.48
Selling, General & Admin	159.03	182.25	144.41	133.42	172.94	146.04
Research & Development	92.52	96.81	108.32	136.93	149.15	96.52
Other Operating Expenses	5.48	6.65	7.11	10.05	5.77	3.75
Operating Expenses	257.51	286.7	263.69	285.62	335.22	250.93
Operating Income	75.8	51.39	14.22	-64.74	0.09	84.55
Interest Expense	-5.73	-5.35	-4.28	-2.42	-2.57	-0.38
Interest & Investment Income	10.36	7.65	9.95	7.07	11.41	1.74
Currency Exchange Gain (Loss)	17.23	17.23	7.09	29.91	-9.63	-21.87
Other Non Operating Income (Expenses)	-8.93	-0.23	0.02	-0.63	-1.31	-0.67
EBT Excluding Unusual Items	88.73	70.7	27.01	-30.81	-2.01	63.37
Impairment of Goodwill	-8.55	-8.55	-	-3.44	-4.78	-
Gain (Loss) on Sale of Investments	3.84	-0.14	0.79	-6.31	0.22	-0.52
Gain (Loss) on Sale of Assets	0.17	0.09	-0.47	0.38	-0.05	-
Asset Writedown	-7.8	-4.29	-0.86	-12.77	-3.34	-0.02
Other Unusual Items	1.55	2.22	6.64	8.39	6.76	9.1
Pretax Income	77.94	60.04	33.11	-44.57	-3.21	71.93
Income Tax Expense	3.21	1.88	1.91	-6.37	-2.93	4.03
Earnings From Continuing Operations	74.73	58.16	31.2	-38.2	-0.28	67.89
Minority Interest in Earnings	1.79	3.21	3.17	5.84	9.14	2.27
Net Income	76.52	61.36	34.37	-32.36	8.87	70.16
Net Income to Common	76.52	61.36	34.37	-32.36	8.87	70.16
Net Income Growth	9.76%	78.55%	-	-	-87.36%	125.86%
Shares Outstanding (Basic)	217	217	215	216	222	190
Shares Outstanding (Diluted)	217	217	215	216	222	190
Shares Change (YoY)	1.03%	0.87%	-0.24%	-2.70%	16.93%	-2.33%
EPS (Basic)	0.35	0.28	0.16	-0.15	0.04	0.37
EPS (Diluted)	0.35	0.28	0.16	-0.15	0.04	0.37
EPS Growth	8.64%	77.02%	-	-	-89.19%	131.25%
Free Cash Flow	130.73	90.87	61.25	63.61	-68.66	-21.3
Free Cash Flow Per Share	0.60	0.42	0.28	0.29	-0.31	-0.11
Dividend Per Share	0.280	0.280	0.150	0.010	0.010	0.200
Dividend Growth	-	86.67%	1400.00%	-	-95.00%	809.27%
Gross Margin	33.85%	34.36%	31.43%	20.74%	18.41%	25.10%
Operating Margin	7.70%	5.22%	1.61%	-6.08%	0.01%	6.33%
Profit Margin	7.77%	6.24%	3.89%	-3.04%	0.49%	5.25%
Free Cash Flow Margin	13.28%	9.23%	6.93%	5.97%	-3.77%	-1.59%
EBITDA	91.38	70.53	38.09	-40.77	18.35	99.26
EBITDA Margin	9.28%	7.17%	4.31%	-3.83%	1.01%	7.42%
D&A For EBITDA	15.58	19.13	23.87	23.97	18.26	14.71
EBIT	75.8	51.39	14.22	-64.74	0.09	84.55
EBIT Margin	7.70%	5.22%	1.61%	-6.08%	0.01%	6.33%
Effective Tax Rate	4.12%	3.14%	5.78%	-	-	5.61%
Revenue as Reported	984.77	983.98	884.26	1,065	1,821	1,337

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.